Matt Hewitt
Stock Analyst at Craig-Hallum
(4.06)
# 1,886
Out of 4,698 analysts
803
Total ratings
46.3%
Success rate
5.5%
Average return
Main Sectors:
Stocks Rated by Matt Hewitt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PARK Park Dental Partners | Maintained: Buy | n/a | $20.75 | - | 8 | Sep 3, 2026 | |
| OMCL Omnicell | Maintained: Buy | n/a | $34.71 | - | 49 | Sep 3, 2026 | |
| OABI OmniAb | Maintained: Buy | $7 | $5.04 | +38.89% | 30 | Aug 17, 2026 | |
| DYAI Dyadic International | Maintained: Buy | $4 | $0.5242 | +663.07% | 14 | Aug 13, 2026 | |
| LGND Ligand Pharmaceuticals | Reiterated: Buy | $370 | $286.90 | +28.96% | 71 | Aug 7, 2026 | |
| CYRX Cryoport | Reiterated: Buy | $20 | $15.78 | +26.74% | 9 | Aug 7, 2026 | |
| CERT Certara | Maintained: Hold | n/a | $8.28 | - | 18 | Aug 4, 2026 | |
| CDXS Codexis | Maintained: Buy | n/a | $1.48 | - | 52 | Jul 24, 2026 | |
| BLFS BioLife Solutions | Downgraded: Hold | $31 | $35.92 | -13.70% | 35 | Jul 22, 2026 | |
| BHST BioHarvest Sciences | Maintained: Buy | n/a | $1.90 | - | 19 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $18.43 | - | 53 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $20.88 | - | 52 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.74 | - | 39 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.27 | - | 36 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $172.94 | - | 57 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.43 | - | 21 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.56 | - | 2 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $12.14 | - | 20 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $3.09 | +94.17% | 55 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $7.38 | -32.25% | 31 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $29.77 | +34.36% | 30 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.4766 | - | 1 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $101.98 | - | 1 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $5.15 | +133.01% | 20 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.44 | - | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.30 | - | 12 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $20.43 | n/a | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $17.40 | n/a | 13 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $42.60 | n/a | 1 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $0.9508 | n/a | 2 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.49 | n/a | 15 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $3.27 | n/a | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.94 | n/a | 1 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.46 | n/a | 22 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $17 | $15.62 | n/a | 2 | Oct 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $100 | $0.0002 | n/a | 1 | Jan 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $215 → $154 | $72.30 | n/a | 3 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $4.55 | n/a | 4 | Feb 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 | $102.92 | n/a | 1 | Nov 8, 2017 |
Park Dental Partners
Sep 3, 2026
Maintained: Buy
Price Target: n/a
Current: $20.75
Upside: -
Omnicell
Sep 3, 2026
Maintained: Buy
Price Target: n/a
Current: $34.71
Upside: -
OmniAb
Aug 17, 2026
Maintained: Buy
Price Target: $7
Current: $5.04
Upside: +38.89%
Dyadic International
Aug 13, 2026
Maintained: Buy
Price Target: $4
Current: $0.5242
Upside: +663.07%
Ligand Pharmaceuticals
Aug 7, 2026
Reiterated: Buy
Price Target: $370
Current: $286.90
Upside: +28.96%
Cryoport
Aug 7, 2026
Reiterated: Buy
Price Target: $20
Current: $15.78
Upside: +26.74%
Certara
Aug 4, 2026
Maintained: Hold
Price Target: n/a
Current: $8.28
Upside: -
Codexis
Jul 24, 2026
Maintained: Buy
Price Target: n/a
Current: $1.48
Upside: -
BioLife Solutions
Jul 22, 2026
Downgraded: Hold
Price Target: $31
Current: $35.92
Upside: -13.70%
BioHarvest Sciences
Jul 15, 2026
Maintained: Buy
Price Target: n/a
Current: $1.90
Upside: -
Jul 8, 2026
Rated: Hold
Price Target: n/a
Current: $18.43
Upside: -
Jul 8, 2026
Maintained: Buy
Price Target: n/a
Current: $20.88
Upside: -
Jul 6, 2026
Maintained: Buy
Price Target: n/a
Current: $4.74
Upside: -
Jul 2, 2026
Maintained: Buy
Price Target: n/a
Current: $1.27
Upside: -
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $172.94
Upside: -
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $7.43
Upside: -
Jun 2, 2026
Maintained: Hold
Price Target: n/a
Current: $4.56
Upside: -
May 19, 2026
Maintained: Buy
Price Target: n/a
Current: $12.14
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: $6
Current: $3.09
Upside: +94.17%
May 8, 2026
Reiterated: Buy
Price Target: $5
Current: $7.38
Upside: -32.25%
May 6, 2026
Reiterated: Buy
Price Target: $40
Current: $29.77
Upside: +34.36%
Mar 25, 2026
Maintained: Buy
Price Target: n/a
Current: $0.4766
Upside: -
Feb 23, 2026
Maintained: Buy
Price Target: n/a
Current: $101.98
Upside: -
Dec 16, 2025
Maintained: Buy
Price Target: $12
Current: $5.15
Upside: +133.01%
Dec 9, 2025
Maintained: Buy
Price Target: n/a
Current: $2.44
Upside: -
Oct 10, 2025
Maintained: Buy
Price Target: n/a
Current: $4.30
Upside: -
Jun 17, 2025
Rated: Hold
Price Target: n/a
Current: $20.43
Upside: n/a
Apr 25, 2025
Maintained: Buy
Price Target: n/a
Current: $17.40
Upside: n/a
Mar 18, 2025
Maintained: Buy
Price Target: n/a
Current: $42.60
Upside: n/a
Dec 18, 2024
Rated: Buy
Price Target: n/a
Current: $0.9508
Upside: n/a
Aug 7, 2024
Maintained: Buy
Price Target: n/a
Current: $1.49
Upside: n/a
Feb 9, 2024
Rated: Buy
Price Target: $6
Current: $3.27
Upside: n/a
Sep 21, 2023
Maintained: Buy
Price Target: n/a
Current: $8.94
Upside: n/a
Feb 23, 2023
Rated: Hold
Price Target: n/a
Current: $6.46
Upside: n/a
Oct 4, 2019
Reiterated: Hold
Price Target: $16 → $17
Current: $15.62
Upside: n/a
Jan 18, 2019
Maintained: Hold
Price Target: $100
Current: $0.0002
Upside: n/a
Oct 31, 2018
Downgraded: Hold
Price Target: $215 → $154
Current: $72.30
Upside: n/a
Feb 27, 2018
Maintained: Buy
Price Target: $19
Current: $4.55
Upside: n/a
Nov 8, 2017
Reiterated: Hold
Price Target: $50
Current: $102.92
Upside: n/a